318 related articles for article (PubMed ID: 18804190)
1. Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis.
Wei X; Gong J; Zhu J; Niu L; Zhu W; Li N; Li J
Int Immunopharmacol; 2008 Dec; 8(13-14):1808-12. PubMed ID: 18804190
[TBL] [Abstract][Full Text] [Related]
2. The suppressive effect of triptolide on chronic colitis and TNF-alpha/TNFR2 signal pathway in interleukin-10 deficient mice.
Wei X; Gong J; Zhu J; Wang P; Li N; Zhu W; Li J
Clin Immunol; 2008 Nov; 129(2):211-8. PubMed ID: 18757245
[TBL] [Abstract][Full Text] [Related]
3. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17.
Li Y; Yu C; Zhu WM; Xie Y; Qi X; Li N; Li JS
Mol Immunol; 2010 Sep; 47(15):2467-74. PubMed ID: 20615550
[TBL] [Abstract][Full Text] [Related]
4. Triptolide ameliorates Crohn's colitis is associated with inhibition of TLRs/NF-κB signaling pathway.
Yu C; Shan T; Feng A; Li Y; Zhu W; Xie Y; Li N; Li J
Fitoterapia; 2011 Jun; 82(4):709-15. PubMed ID: 21376787
[TBL] [Abstract][Full Text] [Related]
5. A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice.
Song J; Matsuda C; Kai Y; Nishida T; Nakajima K; Mizushima T; Kinoshita M; Yasue T; Sawa Y; Ito T
J Pharmacol Exp Ther; 2008 Jan; 324(1):276-83. PubMed ID: 17898319
[TBL] [Abstract][Full Text] [Related]
6. Protection effect of triptolide to liver injury in rats with severe acute pancreatitis.
Zhao YF; Zhai WL; Zhang SJ; Chen XP
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):604-8. PubMed ID: 16286273
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis.
Matsuda C; Ito T; Song J; Mizushima T; Tamagawa H; Kai Y; Hamanaka Y; Inoue M; Nishida T; Matsuda H; Sawa Y
Clin Exp Immunol; 2007 May; 148(2):348-59. PubMed ID: 17437423
[TBL] [Abstract][Full Text] [Related]
8. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice.
Lin N; Liu C; Xiao C; Jia H; Imada K; Wu H; Ito A
Biochem Pharmacol; 2007 Jan; 73(1):136-46. PubMed ID: 17097618
[TBL] [Abstract][Full Text] [Related]
9. Triptolide downregulates Treg cells and the level of IL-10, TGF-β, and VEGF in melanoma-bearing mice.
Liu B; Zhang H; Li J; Lu C; Chen G; Zhang G; Lu A; He X
Planta Med; 2013 Oct; 79(15):1401-7. PubMed ID: 23975869
[TBL] [Abstract][Full Text] [Related]
10. Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine.
Cui D; Hoshii Y; Kawano H; Sugiyama S; Gondo T; Liu Y; Ishihara T
Int Immunopharmacol; 2007 Sep; 7(9):1232-40. PubMed ID: 17630202
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
12. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response.
Wu Y; Wang Y; Zhong C; Li Y; Li X; Sun B
Int Immunopharmacol; 2003 Oct; 3(10-11):1457-65. PubMed ID: 12946442
[TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits the differentiation of Th17 cells and suppresses collagen-induced arthritis.
Wang Y; Jia L; Wu CY
Scand J Immunol; 2008 Oct; 68(4):383-90. PubMed ID: 18782267
[TBL] [Abstract][Full Text] [Related]
14. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
16. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription.
Wang B; Ma L; Tao X; Lipsky PE
Arthritis Rheum; 2004 Sep; 50(9):2995-303. PubMed ID: 15457469
[TBL] [Abstract][Full Text] [Related]
17. Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy.
Gao Q; Shen W; Qin W; Zheng C; Zhang M; Zeng C; Wang S; Wang J; Zhu X; Liu Z
Nephrol Dial Transplant; 2010 Nov; 25(11):3539-47. PubMed ID: 20483955
[TBL] [Abstract][Full Text] [Related]
18. Triptolide protects mice from ischemia/reperfusion injury by inhibition of IL-17 production.
Wu C; Xia Y; Wang P; Lu L; Zhang F
Int Immunopharmacol; 2011 Oct; 11(10):1564-72. PubMed ID: 21621648
[TBL] [Abstract][Full Text] [Related]
19. Triptolide ameliorates colonic fibrosis in an experimental rat model.
Tao Q; Wang B; Zheng Y; Li G; Ren J
Mol Med Rep; 2015 Aug; 12(2):1891-7. PubMed ID: 25845760
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of triptolide on chemokine expression induced by proinflammatory cytokines in human corneal fibroblasts.
Lu Y; Fukuda K; Nakamura Y; Kimura K; Kumagai N; Nishida T
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2346-52. PubMed ID: 15980221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
